More importantly, it provided ACVR1 as a potential therapeutic target and simultaneously presented a concrete starting point for investigating the molecular mechanisms that drive the pathophysiology of FOP. The gene discussed is ACVR1; the disease is fibrodysplasia ossificans progressiva.